Insider Buy/Sell Details for the Healthcare Sector — May 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1639)
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$236.24
Total Value
$47.25K
Shares Held After
200
% of Holdings
100.0%
KalVista Pharmaceuticals, Inc. (KALV)
Audhya Paul K. — CHIEF MEDICAL OFFICER
Shares
2,239
Price
$26.78
Total Value
$59.96K
Shares Held After
150,260
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
760
Price
$578.12
Total Value
$439.37K
Shares Held After
18,876
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,929
Price
$577.13
Total Value
$1.11M
Shares Held After
19,636
% of Holdings
8.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,221
Price
$576.21
Total Value
$703.55K
Shares Held After
21,565
% of Holdings
5.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
809
Price
$575.24
Total Value
$465.37K
Shares Held After
22,786
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
281
Price
$574.13
Total Value
$161.33K
Shares Held After
23,595
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
440
Price
$572.70
Total Value
$251.99K
Shares Held After
23,876
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
860
Price
$571.93
Total Value
$491.86K
Shares Held After
24,316
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
700
Price
$570.92
Total Value
$399.64K
Shares Held After
25,176
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
760
Price
$569.79
Total Value
$433.04K
Shares Held After
25,876
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,040
Price
$568.54
Total Value
$591.28K
Shares Held After
26,636
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
520
Price
$567.36
Total Value
$295.03K
Shares Held After
27,676
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
240
Price
$566.37
Total Value
$135.93K
Shares Held After
28,196
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
280
Price
$564.02
Total Value
$157.93K
Shares Held After
28,436
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
135
Price
$561.21
Total Value
$75.76K
Shares Held After
28,716
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
25
Price
$559.58
Total Value
$13.99K
Shares Held After
28,851
% of Holdings
0.1%
KalVista Pharmaceuticals, Inc. (KALV)
Sweeny Nicole — Chief Commercial Officer
Shares
1,489
Price
$26.78
Total Value
$39.87K
Shares Held After
59,291
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,020
Price
$577.97
Total Value
$589.53K
Shares Held After
40,513
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,620
Price
$577.03
Total Value
$934.80K
Shares Held After
41,533
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$574.57
Total Value
$321.76K
Shares Held After
44,653
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$572.66
Total Value
$343.60K
Shares Held After
45,213
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
717
Price
$571.77
Total Value
$409.96K
Shares Held After
45,813
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
683
Price
$570.84
Total Value
$389.89K
Shares Held After
46,530
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
642
Price
$569.69
Total Value
$365.74K
Shares Held After
47,213
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
958
Price
$568.63
Total Value
$544.75K
Shares Held After
47,855
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$567.42
Total Value
$295.06K
Shares Held After
48,813
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$566.36
Total Value
$181.23K
Shares Held After
49,333
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$564.02
Total Value
$135.37K
Shares Held After
49,653
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$562.16
Total Value
$22.49K
Shares Held After
49,893
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
35
Price
$560.74
Total Value
$19.63K
Shares Held After
49,933
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
45
Price
$560.52
Total Value
$25.22K
Shares Held After
49,968
% of Holdings
0.1%
LivaNova PLC (LIVN)
Bianchi Francesco — Director
Shares
1,800
Price
$75.75
Total Value
$136.35K
Shares Held After
7,228
% of Holdings
19.9%
Hyperfine, Inc. (HYPR)
TEISSEYRE THOMAS — Chief Operating Officer
Shares
6,047
Price
$1.65
Total Value
$9.98K
Shares Held After
678,601
% of Holdings
0.9%
Hyperfine, Inc. (HYPR)
HALE BRETT — CFO and CAO
Shares
6,047
Price
$1.65
Total Value
$9.98K
Shares Held After
599,765
% of Holdings
1.0%
NewAmsterdam Pharma Co N.V. (NAMS)
Kooij Louise Frederika — Chief Accounting Officer
Shares
65,000
Price
$35.69
Total Value
$2.32M
Shares Held After
24,353
% of Holdings
72.7%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
25,582
Price
$26.02
Total Value
$665.52K
Shares Held After
350,987
% of Holdings
6.8%
APTARGROUP, INC. (ATR)
Gong Xiangwei — President, Asia
Shares
4,200
Price
$116.13
Total Value
$487.76K
Shares Held After
10,774
% of Holdings
28.0%
Outlook Therapeutics, Inc. (OTLK)
Haddadin Yezan Munther — Director
Shares
34,000
Price
$0.44
Total Value
$14.96K
Shares Held After
37,167
% of Holdings
91.5%
Outlook Therapeutics, Inc. (OTLK)
THURMAN RANDY H — Director
Shares
5,000
Price
$0.43
Total Value
$2.15K
Shares Held After
5,593
% of Holdings
89.4%
Outlook Therapeutics, Inc. (OTLK)
HILZINGER KURT J — Director
Shares
400,000
Price
$0.44
Total Value
$176.52K
Shares Held After
423,655
% of Holdings
94.4%
MCKESSON CORP (MCK)
Rodgers Thomas L — EVP, Chief Strategy & BDO
Shares
2,388
Price
$761.09
Total Value
$1.82M
Shares Held After
3,090
% of Holdings
43.6%
MCKESSON CORP (MCK)
Lau Michele — EVP and Chief Legal Officer
Shares
3,550
Price
$761.09
Total Value
$2.70M
Shares Held After
3,247
% of Holdings
52.2%
BECTON DICKINSON & CO (BDX)
Feld Michael — EVP, Chief Revenue Officer
Shares
75
Price
$147.35
Total Value
$11.05K
Shares Held After
21,084
% of Holdings
0.4%
NewGenIvf Group Ltd (NIVF)
HRT FINANCIAL LP — 10% Owner
Shares
27,993
Price
$0.92
Total Value
$25.75K
Shares Held After
139,878
% of Holdings
20.0%
Glass House Brands Inc. (GLASF)
Tu William — SVP, Corporate Controller
Shares
5,423
Price
$10.48
Total Value
$56.83K
Shares Held After
0
% of Holdings
100.0%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
67,950
Price
$0.47
Total Value
$31.94K
Shares Held After
763,685
% of Holdings
8.2%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$60.38
Total Value
$1.51M
Shares Held After
1,048,095
% of Holdings
2.3%
Hims & Hers Health, Inc. (HIMS)
WELLS DAVID B — Director
Shares
48,400
Price
$24.23
Total Value
$1.17M
Shares Held After
224,417
% of Holdings
21.6%
IRIDEX CORP (IRIX)
Dizon Romeo R — Chief Financial Officer
Shares
5,004
Price
$1.00
Total Value
$5.00K
Shares Held After
126,004
% of Holdings
4.0%
Showing 51–100 of 1639 transactions (page 2 of 33)